Sales rise 19.00% to Rs 736.71 crore
Net profit of Alembic Pharmaceuticals rose 2.43% to Rs 93.04 crore in the quarter ended March 2017 as against Rs 90.83 crore during the previous quarter ended March 2016. Sales rose 19.00% to Rs 736.71 crore in the quarter ended March 2017 as against Rs 619.07 crore during the previous quarter ended March 2016.For the full year,net profit declined 44.01% to Rs 403.16 crore in the year ended March 2017 as against Rs 720.04 crore during the previous year ended March 2016. Sales declined 0.58% to Rs 3101.47 crore in the year ended March 2017 as against Rs 3119.58 crore during the previous year ended March 2016.
ParticularsQuarter EndedYear EndedMar. 2017Mar. 2016% Var.Mar. 2017Mar. 2016% Var.Sales736.71619.07 19 3101.473119.58 -1 OPM %18.2723.04 -19.8232.27 - PBDT133.67143.96 -7 612.061008.52 -39 PBT111.83119.56 -6 529.09936.31 -43 NP93.0490.83 2 403.16720.04 -44
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
